4.2 Article

Use of herbal medicine for diabetes mellitus in adults from the central-western region of Mexico

期刊

PRIMARY CARE DIABETES
卷 15, 期 6, 页码 1095-1099

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.pcd.2021.08.010

关键词

Herbal medicine; Diabetes mellitus; Self-medication

向作者/读者索取更多资源

This study aimed to assess the prevalence of herbal medicine use among patients with type 2 diabetes in central-western Mexico. The results showed a high prevalence of herbal medicine use (59.2%), which was mainly influenced by education level, time of T2DM diagnosis, presence of complications and comorbidities, and insulin usage. Patients with T2DM tend to consume plants like nopal, moringa, and aloe for treatment, especially when experiencing complications or inadequate glycemic control.
Objective: This study aims to assess the prevalence of herbal medicine (HM) use and factors influencing HM usage including the identification of the main plants consumed by patients with type 2 diabetes mellitus (T2DM) in central-western Mexico. Design: A total of 1862 patients with diabetes were surveyed in public and private hospitals in four states (Guanajuato, Jalisco, Michoacan, and San Luis Potosi) of the central-western region of Mexico. The chisquare test was used to assess associations between HM use and demographic characteristics, such as glucose levels, presence of complications and comorbidities, as well as the selected therapy to treat T2DM. Results: The prevalence of HM use (59.2%) in patients with T2DM was mainly associated with education level (p = 0.001), time of diagnosis of T2DM (p = 0.004), presence of complications (p < 0.001) and comorbidities (p = 0.018) and the use of insulin (p < 0.001). These patients report a higher consumption of herbal medicine compared to those on glycemic control (p < 0.001). The most frequently used medicinal plants to treat T2DM were nopal (54.9%), moringa (26.7%), and aloe (22.1%). Conclusion: The prevalence of HM use to treat T2DM in west-central Mexico is high (59.2%) and its consumption is mostly carried out without the recommendation of a health professional (91.9%). The use of HM increases mainly when the patient uses insulin, during complications of the disease or in patients with an inadequate glycemic control. (c) 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据